Multiple Sclerosis Journals & Insight | Touch Neurology

Filter Specialty

Submit to journal

Submit To The Journals

Multiple Sclerosis

Xavier Montalban, EAN 2020 – Long-term Phase II Outcomes of First Oral BTK Inhibitor in MS
Multiple Sclerosis

Bianca Weinstock-Guttman, EAN 2020 – CHORDS Study in RRMS With Suboptimal Prior Response to DMTs
COVID-19

Andrew Chan, EAN 2020 – COVID-19 and Multiple Sclerosis
Multiple Sclerosis

Ofatumumab – A Potential Subcutaneous B-cell Therapy for Relapsing Multiple Sclerosis

Ron Milo

European Neurological Review. 2020;15(1):Epub ahead of publication
COVID-19

Asaff Harel, April 2020 – COVID-19 and Multiple Sclerosis
COVID-19

Coronavirus and MS Reporting Database Announced by Consortium of Multiple Sclerosis Centers & National Multiple Sclerosis Society
Multiple Sclerosis

NARCRMS Enrollment Milestone: 700 Multiple Sclerosis Participants Enrolled
Multiple Sclerosis

Ozanimod in Multiple Sclerosis

Beyza Ciftci-Kavaklioglu , E Ann Yeh

European Neurological Review. 2019;14(2):73–9 DOI: https://doi.org/10.17925/ENR.2019.14.2.73
Multiple Sclerosis

Tanuja Chitnis – Exploring the Role of the Microbiome in Multiple Sclerosis
Multiple Sclerosis

Expert Panel Discussion – Exploring the Role of the Microbiome in Multiple Sclerosis
Multiple Sclerosis

Exploring the Role of the Microbiome in Multiple Sclerosis

Lloyd Kasper, Tanuja Chitnis, Mirla Avila, Nicole Sconzo, Raymond Ashton, Mark Rametta

US Neurology. 2019:15(2):82–90 DOI: https://doi.org/10.17925/USN.2019.15.2.82
$Autologous Haematopoietic Cell Transplantation for Treatment-refractory Relapsing Multiple Sclerosis$
Multiple Sclerosis

Autologous Haematopoietic Cell Transplantation for Treatment-refractory Relapsing Multiple Sclerosis
Multiple Sclerosis

Discontinuation of Disease-modifying Treatments in Relapsing-remitting Multiple Sclerosis – A Systematic Literature Review of Observational Studies

Gerard T Harty, Schiffon L Wong, Michael Tang, Sangeeta Budhia

European Neurological Review. 2019:14(1):36–43 DOI: https://doi.org/10.17925/ENR.2019.14.1.36
Multiple Sclerosis

Xavier Montalban, EAN 2019 – Phase II study of first oral BTK inhibitor in multiple sclerosis
Multiple Sclerosis

Fernando Dangond, AAN 2019 – Phase II study of first oral BTK inhibitor in multiple sclerosis
Multiple Sclerosis

Dawn Langdon, EAN 2019 – Cognitive assessment in multiple sclerosis
Multiple Sclerosis

Aksel Siva, EAN 2019 – Treatment strategies in multiple sclerosis
Multiple Sclerosis

Aksel Siva, EAN 2019 – Unmet needs in the treatment of progressive multiple sclerosis

Load More Posts

Society Partners & Key Congresses

Quick Links

Other websites from

Touch Medical Media Limited, trading as Touch Medical Media, is a private limited company registered in England and Wales at The White House, Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142. © 2019 All rights reserved.

touchneurology is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.